Document Detail


Topical antifungal agents.
MedLine Citation:
PMID:  1436934     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Current knowledge of fungal cell architecture and biochemistry allows limited understanding of the mode of action of presently available topical antifungal agents. Nystatin, first introduced in the 1950s for treatment of vulvovaginal candidiasis, has been surpassed by the imidazoles and triazoles as the first choice of treatment for vulvovaginal candidiasis. The lack of clear superiority of any one azole agent or dosing regimen leads some authors to recommend a short course of therapy (1-3 days) for acute uncomplicated candidal vaginitis using factors including anatomic distribution of inflammation and patient preference (such as previous hypersensitivity or allergic reaction to the agent, the cost of the agent, and the preferred vehicle for administration of the agent) to choose the specific antifungal agent (see Table 1). Recurrent cases or treatment during pregnancy may require longer therapy (6-14 days), again using an agent chosen because of these factors. Although theoretic risks may exist, actual harm to the fetus or pregnancy has not been demonstrated with the use of the topical azoles during any trimester of pregnancy. The development of antimycotic resistance need not be considered in infrequent and occasional episodes of candidal vaginitis, and it is rarely a cause of treatment failure even in chronic or recurrent cases.
Authors:
J M Ernest
Related Documents :
12076384 - Interventions to help external cephalic version for breech presentation at term.
16897124 - Pregnancy in an untreated case of transverse vaginal septum with vesicovaginal fistula.
16698984 - Impact of a cultural belief about ghost month on delivery mode in taiwan.
21683234 - Fetal lung interstitial tumor: a cause of late gestation fetal hydrops.
18313894 - Fear and disgust propensity in spider phobic distress.
15671994 - Cost-effectiveness and contraceptive effectiveness of the transdermal contraceptive patch.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Obstetrics and gynecology clinics of North America     Volume:  19     ISSN:  0889-8545     ISO Abbreviation:  Obstet. Gynecol. Clin. North Am.     Publication Date:  1992 Sep 
Date Detail:
Created Date:  1992-12-18     Completed Date:  1992-12-18     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  8709551     Medline TA:  Obstet Gynecol Clin North Am     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  587-607     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Wake Forest University Medical Center, Winston-Salem, North Carolina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Antifungal Agents / administration & dosage*,  chemistry,  therapeutic use
Candidiasis, Vulvovaginal / drug therapy*
Female
Humans
Pregnancy
Pregnancy Complications, Infectious / drug therapy*
Chemical
Reg. No./Substance:
0/Antifungal Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antiviral agents.
Next Document:  Evaluation and management of orofacial sensory nerve injuries.